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Stigma in Malay Patients with HIV/AIDS in Malaysia
Nor Asyikin Fadzil* 1’, Zahiruddin Othman2', Mahiran Mustafa3’
ABSTRACT
Background: Previous study noted severe impairment of social well-being, compared to other area of QoL in HIV patients, 
suggesting the role of moral and religious values concerning HIV infection.
Objectives: The objective of this study was to evaluate the level and correlates of HIV-related stigma experienced by the 
patients.
Methods: A total of 100 consenting Malay Muslim HIV patients attending the infectious disease out-patient clinic, Hospital 
Raja Perempuan Zainab II from July 2012 to February 2013 were recruited for study.
Results: (1) Stigma among HIV patients attending out-patient clinic was high, particularly disclosure concerns; (2) Female 
HIV patients had significantly higher disclosure concerns compared to male HIV patients; (3) Among the studied variables, only 
disclosure was independently associated with total stigma.
Conclusion: HIV-related stigma was high and significantly correlated with disclosure of HIV status among Malay Muslim 
HIV patients. Further studies are warranted to determine additional factors, such as culture and religiosity, which may influ­
ence the stigma.
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INTRODUCTION
The first case of HIV/AIDS in Malaysia was reported from the 
University Hospital Kuala Lumpur in late 1986". Since then the number 
of patients living with HIV/AIDS has increased with the current number 
of HIV/AIDS patient in Malaysia being 81,0002>. Stigma towards people 
living with HIV/AIDS (PLHA) is strong in Malaysia3’, even among 
future health providers4”. PLHA face a number of challenges, both in 
terms of the medical management of their disease and the psychosocial 
issues that accompany HIV-infection. Majority of patients (67.3%) on 
methadone maintenance therapy (MMT) were HIV positive61 and the 
high rate of psychiatric disorders among them71 underline the importance 
of adequate psychiatric treatment along the medical treatments. 
Nevertheless, HIV-related stigma has been described as one of the great­
est barriers to dealing effectively with the epidemic worldwide81. Stigma 
has been shown to be a barrier to HIV services uptake and adherence to 
antiretroviral treatment.
Research on stigma has expanded the original definition of stigma 
as a "dynamic process of devaluation that 'significantly discredits' an 
individual in the eyes of others" to include negative social attitudes (per­
ceived stigma), discriminating behaviors (enacted stigma) toward stig­
matized individuals” and self-stigma (or internalized stigma), which 
results from fear of enacted stigma101. Disclosure stigma revolves around 
the decision process of a person living with HIV whether to tell others 
about their HIV/AIDS status and discuss openly about it. This complex 
and varied concept of stigma makes it an interesting, but challenging, 
subject to study.
In a previous cross-sectional study conducted in Kota Bharu111, it 
was found that psychological and social well-being were more affected
than physical well-being among HIV patients. More than a third (38%) 
had possible anxiety, depression or both, and the emotional disturbances 
were significantly associated with lower quality of life (QoL). Patients 
who acquired the HIV infection via a heterosexual route had a signifi­
cantly lower social well-being. It was hypothesized that the severe 
impairment in social well-being in patients with HIV infection was 
attributed to the population that is still very biased and prejudiced 
towards the moral and religious values concerning HIV infection and its 
association with drug misuse and prostitution. The objective of this 
study, therefore, was to evaluate the level and correlates of HIV-related 
stigma experienced by the patients. Since stigma is heavily influenced 
by cultural and religious values, we intentionally limit our study popula­
tion to Malay Muslim patients.
METHODOLOGY
Study setting and  subjects
Kelantan is a rural state situated at the northeastern of Malaysia 
Peninsular. Malay Muslim population constitutes 95% of the population. 
This study was conducted from July 2012 to February 2013 at the infec­
tious disease out-patient clinic, Hospital Raja Perempuan Zainab II 
(HRPZ II) in Kota Bharu, the capital city of Kelantan. This is the only 
centre for infectious disease in the region. More than 5,800 HIV/AIDS 
patient had been treated since its establishment in 1993. This cross-sec­
tional study was approved by the USM Human Research Ethics 
Committee (HREC) and Malaysia Medical Research and Ethics
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Table 1. Stigma according to gender
Stigma Mean (SD)
Male (n =  60) Female (n = 40)
P-value*
Total 122(14.32) 123.68 (20.09) 0.650
Personalized stigma 55.47(8.59) 54.85 (11.66) 0.760
Disclosure concerns 31.52 (3.28) 32.93 (3.90) 0.049
Negative self-image 38.13 (5.60) 38.82 (6.90) 0.580
Concern with public 
attitude
62.82 (7.87) 62.83 (11.53) 0.990
* Independent t test
Committee (MREC). Subjects from each gender (60% males, 40% 
females) were selected according to systematic sampling method. The 
gender ratio corresponded to actual ratio of patients attending the clinic. 
Recruitment was carried on every clinic day until the researcher 
achieved the target of 100 subjects. A total of 100 Malay Muslim HIV/ 
AIDS patients, aged 18-65 years, gave written informed consent after 
given the explanation about the study. All the subjects were cooperative, 
literate and able to understand the Malay language. Those having physi­
cal illness too weak or ill to participate, severe mental illness such as 
schizophrenia or major depressive disorder, learning disability or mental 
retardation, and severe communication problem were excluded from the 
study.
Instrum ents
HIV stigma scale (HSS)
The 40 items of the HSS is rated on a 4-point Likert scale (strongly 
disagree, disagree, agree, strongly agree) to assess stigma experienced 
by an HIV-positive person across the four domains; personalized stigma 
(enacted stigma), disclosure concerns (enacted stigma), negative 
self-image (internalized stigma), and concern with public attitudes (per­
ceived stigma)121. This study used the Malay translated version which 
was available and used in a previous study131. The internal consistency 
reliability 0.92 of the Malay version is comparable to 0.96 of the origi­
nal English version.
Statistical analysis
All the analyses were done using PASW Statistics version 20.0 for 
Windows. Descriptive statistics was used to evaluate socio-demographic 
data. The associations between socio-demographic and clinical variables 
with stigma were analyzed using linear regression analysis to measure 
the strength of the relationship and control the potential confounding 
factors. Model assessment was done by checking the linearity assump­
tions, independent samples, equal variance assumptions and normality 
plus outliers by using standardized residual plots. A model building 
strategy was implemented in which simple linear regression analysis 
were performed with the above variables, and then multivariable regres­
sion analysis were conducted using independent variables which had P
< 0.25. Finally, forward, backward, stepwise and check with enter elimi­
nation strategies were used in which a series of multiple linear regres­
sion analysis were performed. The independent variables with the low­
est P value from the previous analysis were eliminated from subsequent 
analyses so that the final model continued only statistical significant (P
< 0.05) results.
RESULTS
A total of 100 (60 males, 40 females) subjects were recruited. The 
mean age of subjects was 36.0 ± 7.2 years. Most of the subjects were 
married (43%) and, educated up to secondary level (79%), self-em­
ployed (39%), low income of less than RM 1,000 per month (57%), liv­
ing with parent (40%) and received support from family (73%). Of par­
ticular interest is that almost all subjects did not disclose their HIV sta­
tus to family members (96%). The mean duration of illness was 5.2 ± 
3.7 years. Most subjects were infected with HIV through sharing needle
(48%) and were receiving antiretroviral therapy (78%). Single and mul­
tiple sexual partner transmission occurred in 34% and 15%, respective­
ly. Tuberculosis (TB) occurred in 21%, second after hepatitis B and/or 
C. A study conducted in India, found TB to be the most common oppor­
tunistic infection affecting 40% of the HIV patients141.
In this sample, total stigma ranged from 0 to 160 (mean = 122.7 ± 
16.8); personalized stigma subscale ranged from 18 to 72 (mean = 55.2 
± 9.9); disclosure concerns subscale ranged from 10 to 40 (mean = 32.1 
± 3.6); negative self-image stigma subscale ranged from 13 to 52 (mean 
= 38.4 ± 6.2); and concerns with public attitudes subscale ranged from 
20 to 80 (mean = 62.8 ± 9.4).The narrow confidence intervals indicate 
the estimates of the means are quite precise. The total stigma, personal­
ized stigma, disclosure concerns, negative self-image and concern with 
public attitude were 76%, 77%, 80%, 74% and 78% of maximum 
scores, respectively. Disclosure concerns were the highest types of stig­
ma experienced by the subjects in this study. Further, female had more 
disclosure concerns compared to male (P = 0.049). Otherwise, the total 
stigma, personalized stigma, negative self-image and concern with pub­
lic attitude were not significantly different between male and female 
gender, as presented in table 1.
The HSS total stigma was regressed onto each of socio-demograph­
ic and clinical variables by using simple linear regression (SLR) analy­
sis, as presented in table 2. A total of 7 variables had P < 0.25: employ­
ment; highly active antiretroviral therapy (HAART); CD4 count (severi­
ty); route of getting HIV; disclosure; co-infection and history of incar­
ceration. After performing series of forward, backward, stepwise and 
lastly elimination methods in multiple linear regression (MLR) using 
these variables, only disclosure was significantly (P < 0.05) associated 
with total stigma score. Disclosure was a significant correlate for total 
stigma. Patient who disclosed their illness had significantly higher total 
stigma level than the non-disclosure group. This group have 23.58 unit 
(b = 23.58) higher total stigma level than non-disclosure group (95% Cl 
7.19, 39.96) at P < 0.005. However, only 35% of variation in total stig­
ma was explained by disclosure according to the MLR model (R2 = 
0.35). Thus, further studies are warranted to determine other factors that 
may influence the stigma.
DISCUSSIO N
The level of HIV-related stigma in this study was higher compared 
to another study131 conducted in 102 HIV-infected male prisoners in 
Pengkalan Chepa Prison, Kota Bharu, Malaysia. Lower level of stigma 
is probably explained by the limited interaction between the prisoners 
and the society. The prisoners were yet to experience the full effects of 
the stigma until they re-enter the community upon their release. This is 
consistent with unrealistic optimism of prisoners towards their post-re- 
lease success that has been reported elsewhere151. Several local practices 
may maintain the high public attitudes stigma. For instance, public 
health officers conducting home visits for HIV contact tracing, threatens 
to alienate the families for having had an HIV-infected relative. 
Additionally, Muslim burial rite is done with bleach for people who are 
known to be infected with HIV, again reinforcing the societal and indi­
vidual anxiety and stigma towards HIV.
In this study, female HIV patients were found to have significantly 
more disclosure concerns, but not personalized stigma, negative self-im­
age, concern with public attitude or total stigma. This is consistent with 
findings in many areas of the world1'"181 that women with HIV/AIDS are 
blamed and stigmatized more than their male counterparts. Further, a 
local study found the Malays were less likely than other ethnic groups to 
perceive no stigmatization if their spouses were HIV positive191. The rea­
sons for blaming women are thought to be intricately tied to socially 
accepted norms regarding gender-specific roles, responsibilities, and 
sexuality. A study in Vietnam suggested that men and women who vio­
late the norm that "one is meant to act in ways that support and rein­
force the well-being of one’s family" are harshly criticized, but not 
equally171. If a man becomes infected with HIV through drug use or 
"indulging in play,” he is often regarded as a "victim of social evils." In 
contrast, if a woman gets infected, she will be criticized as having vio­
lated core moral norms of the society and simply not tolerated. 
Similarly, high levels of HIV-related stigma were associated with black 
women and living outside urban area181. The study suggested that sexist 
and racist stereotypes continue to permeate HIV discourse, and HIV­
positive women have been positioned as "dirty, diseased and undeserv­
ing"201 and may be blamed and shamed for HIV infection due to lasting 
assumptions of "deviant" sexual behavior e.g. sex work, promiscuity211.
In this study, disclosure was the only factor independently associat-
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Table 2. Factors associated with stigma by simple linear regression analysis
Frequency
b ' (95%  C l)
S im ple L inear R egression  
T  statis tic P -value
A ge (M ean  ±  SD ) 36.0  ±  7.2 -0 .02 (-0 .48 , 0 .45) -0.07 0.943
18-29 20
30-39 40
40-49 32
> 50 3
G ender
M ale 60 -1 .68  (-5 .15 , 8 .50) 0.49 0.628
Fem ale 40 - - -
M arital status
M arried 43 -0 .32  (-7 .08 , 6 .45) -0 .09 0.926
Single 30 -1 .34  (-8 .6 4 ,5 .9 7 ) -0 .36 0.717
D ivorced 14 -1 .34  (-8 .6 4 ,5 .9 7 ) -0 .36 0.717
W idow 13 - - -
E ducation  level
N o 2 - - -
Prim ary 11 2.72 (-7 .97 , 13.41) 0.60 0.615
S econdary 79 -1 .74  (-9 .96 ,6 .47) 0.42 0.675
Tertiary 8 -2 .22  (-14 .56 , 10.12) 0.36 0.721
E m ploym ent
S elf-em ployed 39 - - -
G overnm ent 13 -2 .72 (-12 .66 , 7.23) -0.54 0.589
P rivate sector 19 7.36  (-1 .05 , 12.77) 1.74 0.086
U nem ployed 29 -0 .56  (-7 .94 , 6 .83) -0.15 0.882
Incom e per m onth
< RM  1,000 57 -1 .48 (-8 .24 , 5.28) -0.43 0.666
RM  1,000-2,000 19 - - -
>  RM  2,000 24 -3 .86  (-11 .78 , 4 .06) -0.97 0.336
L iv ing  arrangem ent
A lone 8 0.36  (-11 .99 , 12.70) 0.06 0.954
S pouse 39 0.16  (-6 .70 , 7.03) 0.05 0.963
Friend 13 - - -
P arent 40 3.63 (-3 .17 , 10.43) 1.06 0.291
Support from  fam ily
Yes 73 3.55 (-3 .96 , 11.06) 0.94 0.351
N o 27 - - -
C irc le  o f  confiden tiality
N ot d isclosed 96 - - -
D isclosed 4 26.22  (9 .96 , 42 .48) 3.20 0.002
D uration  o f  illness (M ean ±  SD ) 5.2 ± 3 .7 -0 .29  (-1 .19 , 0 .61) -0.65 0.521
Source o f  H IV  infection
In jec ting  needle 48 0.11 (-0 .66 , 6.82) 0.03 0.973
M ultip le  sexual partner 15 -4.95 (-14 .27 , 4 .38) -1.05 0.295
S ingle sexual partner 34 7.50  (0 .59 , 14.41) 2.15 0.034
other 3 - - -
CD4* coun t
< 2 0 0 7 4.76  (-3 .41 , 12.93) 1.16 0.251
200-350 39 -5 .47 (-12 .25 , 1.31) -1.60 0.113
> 3 5 0 35 1.21 (-5 .81 , 8.23) 0.34 0.733
A ntire trov iral therapy  (H A A R T)
Yes 78 -2 .99  (-1 1 .0 5 ,5 .0 7 ) -0 .74 0.521
N ever 20 5.16  (-3 .15 , 13.47) 1.23 0.221
R eceived  but cu rren tly  not 2
C o-in fection
N o 34 2.86  (-4 .1 9 ,9 .9 1 ) 0.80 0.422
T uberculosis 21 -3 .86  (-1 1 .2 0 ,3 .4 8 ) -1.04 0.300
H epatitis  B and /o r C 29 6.14  (-1 .99 , 14.27) 1.50 0.137
M ore than  1 co-in fection 12 -9 .85 (-19 .97 , 0 .26) -1.93 0.056
O ther illness 4 - - -
JCrude regression coefficient
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ed with high HIV-related stigma. As HIV/AIDS is a highly stigmatized 
illness, disclosing one's HIV status may lead to discrimination. For 
instance, HIV patients risk being rejected from work and family. High 
HIV-related stigma among HIV patients in this study probably 
explained the severe impairment of social well-being, compared to other 
area of QoL, of HIV patients in the previous study"1 234567. However, it is pre­
mature to conclude that the high stigma is related to cultural, moral and 
religious values of the HIV patients and/or local population at this point. 
In conclusion; (1) stigma among HIV patients attending out-patient clin­
ic was high, even when compared with HIV-infected male prisoners13’ in 
same locality; (2) Female HIV patients had significantly higher disclo­
sure concerns compared to male HIV patients; (3) Among the studied 
variables, only disclosure was independently associated with total stig­
ma. Future studies need to look into specific details of cultural, moral 
and religious factors that may influence stigma.
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